Master Pharm SA

Informe acción WSE:MPH

Capitalización de mercado: zł119.7m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Master Pharm Crecimiento futuro

Future controles de criterios 0/6

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Personal Products7.6%
Tasa de crecimiento de los ingresosn/a
Rentabilidad financiera futuran/a
Cobertura de analistas

None

Última actualizaciónn/a

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

Calculating The Intrinsic Value Of Master Pharm SA (WSE:MPH)

Feb 05
Calculating The Intrinsic Value Of Master Pharm SA (WSE:MPH)

Returns On Capital At Master Pharm (WSE:MPH) Have Hit The Brakes

Dec 13
Returns On Capital At Master Pharm (WSE:MPH) Have Hit The Brakes

A Look At The Intrinsic Value Of Master Pharm SA (WSE:MPH)

May 25
A Look At The Intrinsic Value Of Master Pharm SA (WSE:MPH)

Master Pharm (WSE:MPH) Will Will Want To Turn Around Its Return Trends

Mar 30
Master Pharm (WSE:MPH) Will Will Want To Turn Around Its Return Trends

Is Master Pharm SA's (WSE:MPH) Latest Stock Performance Being Led By Its Strong Fundamentals?

Mar 02
Is Master Pharm SA's (WSE:MPH) Latest Stock Performance Being Led By Its Strong Fundamentals?

I Ran A Stock Scan For Earnings Growth And Master Pharm (WSE:MPH) Passed With Ease

Feb 04
I Ran A Stock Scan For Earnings Growth And Master Pharm (WSE:MPH) Passed With Ease

Master Pharm (WSE:MPH) Is Growing Earnings But Are They A Good Guide?

Jan 08
Master Pharm (WSE:MPH) Is Growing Earnings But Are They A Good Guide?

Here's What To Make Of Master Pharm's (WSE:MPH) Returns On Capital

Dec 18
Here's What To Make Of Master Pharm's (WSE:MPH) Returns On Capital

Master Pharm SA (WSE:MPH) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Nov 27
Master Pharm SA (WSE:MPH) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Master Pharm no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

WSE:MPH - Estimaciones futuras de los analistas y datos financieros pasados (PLN Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
6/30/20227921517N/A
3/31/20227341717N/A
12/31/20217741013N/A
9/30/202172-31014N/A
6/30/202175246N/A
3/31/202169168N/A
12/31/20206101315N/A
9/30/202063121517N/A
6/30/202068131516N/A
3/31/202071121213N/A
12/31/2019711367N/A
9/30/2019739910N/A
6/30/201974989N/A
3/31/2019729910N/A
12/31/201875111314N/A
9/30/2018751135N/A
6/30/2018701046N/A
3/31/201868914N/A
12/31/2017648-6-3N/A
9/30/2017577-41N/A
6/30/2017526-42N/A
3/31/2017518-16N/A
12/31/2016497-15N/A
9/30/201650835N/A
6/30/201653745N/A
3/31/2016539N/A1N/A
12/31/2015498N/A3N/A
9/30/2015438N/A4N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Insufficient data to determine if MPH's forecast earnings growth is above the savings rate (2.6%).

Beneficios vs. Mercado: Insufficient data to determine if MPH's earnings are forecast to grow faster than the Polish market

Beneficios de alto crecimiento: Insufficient data to determine if MPH's earnings are expected to grow significantly over the next 3 years.

Ingresos vs. Mercado: Insufficient data to determine if MPH's revenue is forecast to grow faster than the Polish market.

Ingresos de alto crecimiento: Insufficient data to determine if MPH's revenue is forecast to grow faster than 20% per year.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Insufficient data to determine if MPH's Return on Equity is forecast to be high in 3 years time


Descubre empresas en crecimiento